PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Antonin LEVY, MD
Gustave Roussy, Cancer Campus, Grand Paris
Principal Investigator - Benjamin BESSE, MD
Gustave Roussy, Cancer Campus, Grand Paris
Principal Investigator - Jérôme DOYEN, MD
Centre Antoine Lacassagne
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
58 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Institut de Cancérologie de L'Ouest - Site Paul Papin
Angers, France
- Centre Marie Curie
Arras, France
- Hôpital Privé Arras Les Bonnettes
Arras, France
- Institut Sainte Catherine
Avignon, France
- Centre Pierre Curie
Beuvry, France
- Clinique Ambroise Pare
Beuvry, France
- Hôpital Simone Veil Blois
Blois, France
- Institut Bergonie
Bordeaux, France
- Chru de Brest
Brest, France
- Centre François Baclesse
Caen, France
- Centre Hospitalier Universitaire de Caen - Hôpital Cote de Nacre
Caen, France
- Centre Hospitalier Dr Jean-Eric Techer
Calais, France
- Centre Hospitalier de Cannes Simone Veil
Cannes, France
- Centre Hospitalier William Morey
Chalon-sur-Saône, France
- Institut de Cancérologie de Bourgogne
Chalon-sur-Saône, France
- Pôle Départemental de Cancérologie Libérale 37
Chambray-lès-Tours, France
- Centre Jean Perrin
Clermont-Ferrand, France
- Centre Hospitalier Intercommunal de Creteil
Créteil, France
- Centre Georges Francois Leclerc
Dijon, France
- Institut de Cancérologie de Bourgogne
Dijon, France
- Polyclinique Du Parc Drevon
Dijon, France
- Centre André Dutreix
Dunkirk, France
- Centre Hospitalier de Dunkerque
Dunkirk, France
- Centre de Radiothérapie Et de Cancérologie de Blois
La Chaussée-Saint-Victor, France
- Chu Sud de la Réunion
La Réunion, France
- Hôpital de Bicêtre
Le Kremlin-Bicêtre, France
- Centre Oscar Lambret
Lille, France
- Clinique Chenieux
Limoges, France
- Hôpital Européen Marseille
Marseille, France
- Hôpital Privé Clairval
Marseille, France
- Centre de Cancérologie Du Grand Montpellier-Clinique Clementville
Montpellier, France
- Centre Hospitalier de Montelimar
Montélimar, France
- Centre Hospitalier Des Pays de Morlaix
Morlaix, France
- Centre Azuréen de Cancérologie
Mougins, France
- Hôpital Privé Arnault Tzanck
Mougins, France
- Centre Antoine Lacassagne
Nice, France
- Chu de Nîmes
Nîmes, France
- Fondation Hôpital Saint-Joseph
Paris, France
- Hopital Pitie Salpetriere
Paris, France
- Hopital Tenon
Paris, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Jan 2018
- Primary completion
- 22 Dec 2026
- Completion
- 22 Dec 2026
- Last update posted
- 25 Feb 2026
- Registered enrollment
- 327
- Registry id
- NCT03774732
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.